Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001
Published online before print December 13, 2001, doi: 10.1161/hh0202.103613
A more recent version of this article appeared on February 8, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/2/128    most recent
hh0202.103613v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsuruda, T.
Right arrow Articles by Burnett Jr, J. C.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tsuruda, T.
Right arrow Articles by Burnett Jr, J. C.
Related Collections
Right arrow Cell biology/structural biology
Right arrow Growth factors/cytokines

Submitted on May 25, 2001
Revised on December 3, 2001
Accepted on December 3, 2001

Cardiotrophin-1 Stimulation of Cardiac Fibroblast Growth. Roles for Glycoprotein 130/Leukemia Inhibitory Factor Receptor and the Endothelin Type A Receptor

Toshihiro Tsuruda *, Michihisa Jougasaki , Guido Boerrigter , Brenda K. Huntley , Horng H. Chen , Antonino B. D'Assoro , Shang C. Lee , Amy M. Larsen , Alessandro Cataliotti , and John C. Burnett Jr

From the Cardiorenal Research Laboratory, Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, Minn.

* To whom correspondence should be addressed. E-mail: tsuruda.toshihiro{at}mayo.edu.

Cardiotrophin-1 (CT-1), a member of the interleukin-6 superfamily, and endothelin-1 (ET-1) are potent hypertrophic factors in cardiomyocytes. Although CT-1 and ET-1 gene expression in the heart is upregulated in experimental heart failure, their role in the activation of the cardiac fibroblast is unknown. This study was designed to identify the presence and action of CT-1 and its receptor complex, glycoprotein130 (gp130) and leukemia inhibitory factor (LIF) receptor, on cardiac fibroblast growth in cultured adult canine cardiac fibroblasts. In addition, we investigated the interaction between CT-1/gp130/LIF receptor and ET-1/endothelin type A (ETA) receptor axis. Immunohistochemistry was performed using the indirect immunoperoxidase method, while we assessed the cell cycle of cardiac fibroblasts by flow cytometry, DNA synthesis by [3H]thymidine incorporation, and collagen synthesis by [3H]proline incorporation, respectively. CT-1 and gp130/LIF receptor were widely present in the cytoplasm of the cardiac fibroblasts. Exogenous CT-1 markedly stimulated [3H]thymidine and [3H]proline incorporations (P<0.01), with accumulation of cells in the S phase. Blockade of gp130 or LIF receptor inhibited basal growth as well as CT-1-- or ET-1--stimulated cardiac fibroblast growth. The specific ETA receptor antagonist, BQ123, significantly inhibited CT-1--stimulated DNA synthesis. This study demonstrates that CT-1 and its receptors are present in cardiac fibroblasts. In addition, growth of these cells stimulated by endogenous and exogenous CT-1 requires gp130/LIF receptor as well as ETA receptor activation. We conclude that gp130/LIF receptor and ETA receptor activation are essential for cardiac fibroblast growth by CT-1 and that there is synergism with ET-1/ETA receptor axis.


Key words: cardiac fibroblast • cardiotrophin-1 • glycoprotein130 • leukemia inhibitory factor receptor • endothelin-type A receptor




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
O. Lisy, B. K. Huntley, D. J. McCormick, P. A. Kurlansky, and J. C. Burnett Jr
Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NP.
J. Am. Coll. Cardiol., July 1, 2008; 52(1): 60 - 68.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Ichiki, M. Jougasaki, M. Setoguchi, J. Imamura, H. Nakashima, T. Matsuoka, M. Sonoda, K. Nakamura, S. Minagoe, and C. Tei
Cardiotrophin-1 stimulates intercellular adhesion molecule-1 and monocyte chemoattractant protein-1 in human aortic endothelial cells
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H750 - H763.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. Natal, M. A. Fortuno, P. Restituto, A. Bazan, I. Colina, J. Diez, and N. Varo
Cardiotrophin-1 is expressed in adipose tissue and upregulated in the metabolic syndrome
Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E52 - E60.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
M. Kang, K. Y. Chung, and J. W. Walker
G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart
Physiology, June 1, 2007; 22(3): 174 - 184.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
D. W. Ho, Z. F. Yang, C. K. Lau, K. H. Tam, J. Y. To, R. T. Poon, and S. T. Fan
Therapeutic Potential of Cardiotrophin 1 in Fulminant Hepatic Failure: Dual Roles in Antiapoptosis and Cell Repair
Arch Surg, November 1, 2006; 141(11): 1077 - 1084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
O. Zolk, S. Engmann, F. Munzel, and R. Krajcik
Chronic cardiotrophin-1 stimulation impairs contractile function in reconstituted heart tissue
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1214 - E1221.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. H. Freed, R. H. Cunnington, A. L. Dangerfield, J. S. Sutton, and I. M.C. Dixon
Emerging evidence for the role of cardiotrophin-1 in cardiac repair in the infarcted heart
Cardiovasc Res, March 1, 2005; 65(4): 782 - 792.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. A. Narmoneva, R. Vukmirovic, M. E. Davis, R. D. Kamm, and R. T. Lee
Endothelial Cells Promote Cardiac Myocyte Survival and Spatial Reorganization: Implications for Cardiac Regeneration
Circulation, August 24, 2004; 110(8): 962 - 968.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. H Freed, A. M Borowiec, T. Angelovska, and I. M.C Dixon
Induction of protein synthesis in cardiac fibroblasts by cardiotrophin-1: integration of multiple signaling pathways
Cardiovasc Res, November 1, 2003; 60(2): 365 - 375.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Trikha, R. Corringham, B. Klein, and J.-F. Rossi
Targeted Anti-Interleukin-6 Monoclonal Antibody Therapy for Cancer: A Review of the Rationale and Clinical Evidence
Clin. Cancer Res., October 15, 2003; 9(13): 4653 - 4665.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. W Weiss, W. S Speidl, C. Kaun, G. Rega, C. Springer, K. Macfelda, U. M Losert, S. L Grant, M. L Marro, A. D Rhodes, et al.
Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes
Cardiovasc Res, September 1, 2003; 59(3): 628 - 638.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. Tsuruda, G. Boerrigter, B. K. Huntley, J. A. Noser, A. Cataliotti, L. C. Costello-Boerrigter, H. H. Chen, and J. C. Burnett Jr
Brain Natriuretic Peptide Is Produced in Cardiac Fibroblasts and Induces Matrix Metalloproteinases
Circ. Res., December 13, 2002; 91(12): 1127 - 1134.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
I. M.C. Dixon
A new altruist on the block: effects of adrenomedullin after myocardial infarction
Cardiovasc Res, December 1, 2002; 56(3): 347 - 349.
[Full Text] [PDF]


Home page
CirculationHome page
M. R. Bristow and C. S. Long
Cardiotrophin-1 in Heart Failure
Circulation, September 17, 2002; 106(12): 1430 - 1432.
[Full Text] [PDF]